FDA Import Refusal NUV-3855286-8/10002/1 — Eli Lilly & Company
The FDA refused shipment NUV-3855286-8/10002/1 from Eli Lilly & Company (United States) on Nov 3, 2025. The refused product falls under Drugs and Biologics — IXEKIZUMAB. Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 3, 2025
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 58MCP11 IXEKIZUMAB
- Charges
- 179